Curaleaf Hldgs Inc (CURLF)

EQNX::TICKER_START (OTCQB:LUFFF),(CSE:HERB),(NASDAQ:VFF),(OTCQX:CURLF),(OTCQX:GTBIF),(OTCQX:TCNNF) EQNX::TICKER_END

Rapid regulatory expansion, rising patient demand, and accelerating physician adoption are fueling what many analysts believe could become Europe’s next major healthcare investment opportunity

New regulations approved by Texas health officials will force retailers to remove smokable hemp products from store shelves before the end of March.

New regulations approved by Texas health officials will force retailers to remove smokable hemp products from store shelves before the end of March.

Is Green Thumb or Curaleaf better positioned to benefit from marijuana rescheduling?

EQNX::TICKER_START (OTCQB:LUFFF),(CSE:HERB),(NASDAQ:HITI),(OTCQX:TCNNF),(OTCQX:GLASF),(OTCQX:CURLF) EQNX::TICKER_END

The Justice Department (DOJ) has rescheduled certain marijuana products, signaling a notable policy shift after decades of strict federal control. Acting AG Todd Blanche announced that cannabis products approved by the FDA or authorized under state medical cannabis programs will be moved from Schedule I to Schedule III.

The Justice Department (DOJ) has rescheduled certain marijuana products, signaling a notable policy shift after decades of strict federal control. Acting AG Todd Blanche announced that cannabis products approved by the FDA or authorized under state medical cannabis programs will be moved from Schedule I to Schedule III.

These companies are major players in the U.S. marijuana market, and they all generated more than $1 billion in revenue last year.

The Trump administration recently rescheduled medical marijuana from a Schedule I to Schedule III substance.

The oral thin film drug delivery market is entering a high-growth phase, with industry forecasts projecting expansion from $3.30 billion in 2025 to $5.21 billion by 2030, representing a 9.56% CAGR . As demand accelerates for faster, more efficient drug delivery systems , companies positioned at the forefront of this innovation—such as Rapid Dose Therapeutics (CSE: DOSE) (OTCQB: RDTCF)—are increasingly drawing investor attention.

A newly published study points to a possible step forward in efforts to create a cannabis breathalyzer, offering early evidence that a compact and affordable device could detect recent cannabis use without requiring laboratory testing.

A newly published study points to a possible step forward in efforts to create a cannabis breathalyzer, offering early evidence that a compact and affordable device could detect recent cannabis use without requiring laboratory testing.

In a paradoxical display of market confidence, shares of Tilray Brands (NASDAQ:TLRY) surged over 8% on Wednesday following the release of its fiscal third-quarter 2026 financial results. While the company delivered a "record" revenue performance of $206.7 million, outstripping analyst estimates of $201.3 million, it fell significantly

The cannabis REIT has fallen more than 6% so far this year. Is it time to buy the stock?

Federal prosecutors have charged four individuals accused of operating multiple illegal cannabis cultivation sites across the Las Vegas Valley, according to information obtained by the 8 News Now Investigators.

Federal prosecutors have charged four individuals accused of operating multiple illegal cannabis cultivation sites across the Las Vegas Valley, according to information obtained by the 8 News Now Investigators.

Two issues that rarely share political ground are now colliding at the highest court in the country. Firearm rights and marijuana policy have each reshaped U.S. law and politics over the past few decades. Recently, they met in a Supreme Court case that has produced an unexpected mix of allies and opponents.

Two issues that rarely share political ground are now colliding at the highest court in the country. Firearm rights and marijuana policy have each reshaped U.S. law and politics over the past few decades. Recently, they met in a Supreme Court case that has produced an unexpected mix of allies and opponents.

Kentucky marijuana officials are urging lawmakers to broaden the list of medical conditions that qualify patients for a medical cannabis card. In a letter sent Thursday to top legislative leaders, the OCM outlined its case for expanding eligibility under the state’s relatively new program.

Kentucky marijuana officials are urging lawmakers to broaden the list of medical conditions that qualify patients for a medical cannabis card. In a letter sent Thursday to top legislative leaders, the OCM outlined its case for expanding eligibility under the state’s relatively new program.

Rescheduling cannabis to a Schedule 3 drug, if it happens, represents a long-term industry tailwind.

Florida officials under Governor Ron DeSantis are stepping up their opposition to a proposed ballot measure that would allow recreational marijuana, drawing county election offices into the fight and prompting accusations that the state is trying to derail the effort before voters weigh in.